Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 40% ± 17% | |
interneuron | 5 studies | 27% ± 10% | |
oligodendrocyte precursor cell | 5 studies | 22% ± 4% | |
GABAergic neuron | 5 studies | 26% ± 5% | |
glutamatergic neuron | 4 studies | 35% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 8450.38 | 2559 / 2642 | 100% | 378.51 | 703 / 705 |
adrenal gland | 0% | 0 | 0 / 258 | 13% | 0.77 | 29 / 230 |
breast | 0% | 0 | 0 / 459 | 4% | 2.97 | 46 / 1118 |
eye | 0% | 0 | 0 / 0 | 4% | 0.09 | 3 / 80 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.12 | 11 / 459 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.51 | 4 / 178 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.03 | 7 / 504 |
lung | 0% | 0 | 0 / 578 | 1% | 0.06 | 15 / 1155 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.17 | 5 / 430 |
esophagus | 0% | 0 | 0 / 1445 | 1% | 0.02 | 2 / 183 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.02 | 4 / 502 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.01 | 7 / 901 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.01 | 2 / 286 |
thymus | 0% | 0 | 0 / 653 | 1% | 0.02 | 4 / 605 |
intestine | 0% | 0 | 0 / 966 | 1% | 0.06 | 3 / 527 |
liver | 0% | 0 | 0 / 226 | 0% | 0.13 | 2 / 406 |
skin | 0% | 0 | 0 / 1809 | 0% | 0.01 | 2 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0001501 | Biological process | skeletal system development |
GO_0010001 | Biological process | glial cell differentiation |
GO_0007155 | Biological process | cell adhesion |
GO_0007417 | Biological process | central nervous system development |
GO_0005615 | Cellular component | extracellular space |
GO_0005796 | Cellular component | Golgi lumen |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0045202 | Cellular component | synapse |
GO_0005576 | Cellular component | extracellular region |
GO_0072534 | Cellular component | perineuronal net |
GO_0005509 | Molecular function | calcium ion binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005540 | Molecular function | hyaluronic acid binding |
Gene name | NCAN |
Protein name | Neurocan Neurocan core protein (Chondroitin sulfate proteoglycan 3) |
Synonyms | CSPG3 NEUR |
Description | FUNCTION: May modulate neuronal adhesion and neurite growth during development by binding to neural cell adhesion molecules (NG-CAM and N-CAM). Chondroitin sulfate proteoglycan; binds to hyaluronic acid. |
Accessions | O14594 K7EKF8 ENST00000252575.11 ENST00000588231.1 |